Imagine battling a stroke at 90 years old or more – and winning back your independence thanks to a groundbreaking procedure. But is age really just a number when it comes to life-saving treatments?
In a surprising turn that challenges traditional thinking, researchers have discovered that endovascular thrombectomy (EVT) can significantly enhance recovery and lower death rates in stroke patients over the age of 90, outperforming standard medical care alone. This revelation comes from a study comparing these two approaches in 149 individuals dealing with acute large vessel occlusion (LVO), a severe type of stroke that blocks major brain blood vessels. The lead investigator, Xiaobo Guan, MD, from the First Affiliated Hospital of Xinjiang Medical University in Urumqi, China, emphasizes that being advanced in years shouldn't automatically rule out EVT as an option.
"As people live longer and our global population ages, we're seeing more cases of acute ischemic stroke in those over 90," the team explains. "This poses a big challenge because we still don't fully understand the risks and benefits of EVT for these very elderly folks." Their work, published on October 25 in Academic Radiology, sheds light on this uncertainty.
For those new to this, EVT is a minimally invasive procedure guided by imaging technology to break up and remove blood clots in stroke patients, restoring vital blood flow to the brain and stopping further damage. It's become the go-to treatment for acute ischemic strokes caused by LVO, but clinical trials have rarely included participants in their nineties, leaving a gap in our knowledge.
To fill that void, the researchers evaluated outcomes from 52 patients (34.9% of the total) who underwent EVT and 97 (65.1%) who received the best medical management, or BMM, at their hospital from January 2020 through December 2024. All participants arrived within 24 hours of symptom onset, and LVO was verified via an initial CT angiography scan. The average age in the group was 92 (ranging from 90 to 95), with 41.6% being men.
The BMM approach included treatments like intravenous thrombolysis (a medication to dissolve clots), antiplatelet or anticoagulant drugs to prevent clotting, neuroprotective agents to protect brain cells, and other supportive care. Importantly, if someone in the BMM group worsened and later needed a rescue thrombectomy, they were still counted as BMM because EVT wasn't the initial plan.
The results showed EVT linked to notably better functional recovery at 90 days post-stroke, measured by the modified Rankin scale (mRS) – a simple tool that rates disability from 0 (no symptoms) to 6 (dead). Scores of 0-2 indicate functional independence, meaning the person can live daily life without much help. In the EVT group, 15.4% reached this level compared to just 7.2% in the BMM group, with the difference being statistically significant (p=0.04). Even for the stricter "favorable outcome" of mRS 0-1 (almost full recovery), EVT edged ahead at 6.9% versus 2.2% for BMM, though this didn't quite hit the statistical threshold.
"Our results indicate that age by itself shouldn't stop us from considering EVT," the authors state. "With careful patient selection, those in their nineties can still gain real benefits from prompt restoration of blood flow."
Yet, the overall picture isn't all rosy. Death rates at 90 days were high in both groups – 40.2% for EVT and 57.2% for BMM – highlighting the harsh realities of strokes in this age bracket. This calls for "realistic hopes and personalized choices in treatment," the team cautions.
They urge more studies to refine how we choose patients and care for them after the procedure in this vulnerable demographic.
But here's where it gets controversial: Are we pushing too hard for aggressive interventions in the elderly, risking unnecessary complications for minimal gains? Or should we embrace every chance to improve quality of life, no matter the cost? This debate touches on ethics, healthcare resources, and what 'quality of life' means for someone over 90. What do you think – should age limits on treatments like EVT be a thing of the past, or is there a point where we let nature take its course? Share your thoughts in the comments; I'd love to hear differing views!
For the complete details, check out the full study here: https://doi.org/10.1016/j.acra.2025.10.011.
